esketamine

Nasal spray drug related to ketamine approved by FDA to treat depression

The U.S. Food and Drug Administration on Tuesday approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression. The Johnson & Johnson nasal spray is a variation of the anesthetic ketamine — a pain reliever that was…